New antibody combo could shield kids from rabies after bites
NCT ID NCT07327307
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 232 children under 18 who received a new antibody injection (zamerovimab and mazorelvimab) plus the rabies vaccine after a severe animal bite. Researchers track whether the children stay rabies-free for up to one year. The goal is to see if this combination prevents rabies effectively in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Zamerovimab and Mazorelvimab injection (antibodies) plus rabies vaccine
- What this could lead to
- If successful, this could confirm a new antibody treatment that, combined with the vaccine, prevents rabies after severe bites in children.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less definitive. Rabies is rare, so proving effectiveness is challenging.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES POST-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Nanhua Hospital, University of South China
RECRUITINGHengyang, Hunan, China
-
Hunan Provincial People's Hospital
RECRUITINGChangsha, Hunan, China
-
Jiangxi Provincial Chest Hospital
RECRUITINGNanchang, Jiangxi, China
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Shenzhen second people's hospital
RECRUITINGShenzhen, Guangdong, China
-
The University of Hong Kong - Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.